Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Strategic alliance expands company's product portfolio
A new protein, which will help scientists to understand why nerve cells die in people with Alzheimer’s disease, has been designed in a University of Sussex laboratory
Robert Gaertner from Veeva Systems makes the case that cloud-based collaboration increases productivity and transparency, and reduces quality risks in the life sciences supply chain
FDA guidance and workshop indicates development of fast emerging liquid biopsy field
Protein-based therapeutic may play an important role in allowing certain cells to become cancerous
A great opportunity for businesses to get their brand, products and equipment in front of a high profile audience and celebrate the innovation that the industry has to offer
New distributors enhance customer support by offering local hours, local language and local service and inventory at the point of final distribution
Antibody-drug conjugates could hold the key to delivering highly potent anticancer drugs more accurately to the tumour site with less damage to healthy cells
Company establishes Center of Excellence for Oncology in San Diego
In this second article of a two-part series, John Farris, CIH, and Robert Sussman, PhD DABT, SafeBridge Consultants, cover the safe handling of antibody-drug conjugates in pharmaceutical facilities and the control measures needed to protect workers from exposure risks
Comments invited on a concept paper on changes intended to support best practices
Environmental Monitoring is a GMP requirement to ensure drug products are made in a non-contaminating environment. Andrew Ramage and Harshad Joshi, Cherwell Laboratories, give a scientific and regulatory perspective on considerations when using neutralisers in growth media